Document Detail


Intractable Prinzmetal's angina three months after implantation of sirolimus-eluting stent.
MedLine Citation:
PMID:  18987406     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sirolimus-eluting stents (SES) prevent neointimal proliferation and have been widely used to treat stenotic lesions in coronary arteries because of a significant reduction of restenosis in comparison with bare-metal stents. Sirolimus, however, may cause endothelial dysfunction by damage to vascular endothelium or impairing vascular repair. Recent studies report the occurrence of exercise- or acetylcholine-induced coronary vasoconstriction in the vessel segments adjacent to the SES. We report here a clinical case of intractable Prinzmetal's angina 3 months after SES implantation and recommend extended, thorough follow up of patients who have undergone SES implantation.
Authors:
Mitsuru Abe; Akemi Yoshida; Yoritaka Otsuka
Related Documents :
22016106 - Thrombolytic effects of a combined therapy with targeted microbubbles and ultrasound in...
16642286 - Duplex ultrasound verified by angiography in patients with severe primary and restenosi...
16881976 - Sirolimus-eluting stent in chronic total occlusion: the sicto study.
14769766 - Tracheobronchial amyloidosis: a case report of successful treatment with external beam ...
20300236 - Stenting the ductus arteriosus: case selection, technique and possible complications.
8542626 - Balloon mitral valvotomy in patients with systemic and suprasystemic pulmonary artery p...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  20     ISSN:  1557-2501     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-11-06     Completed Date:  2009-03-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  E306-9     Citation Subset:  IM    
Affiliation:
Division of Cardiology, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, 565-8565, Japan. mitsuru@ hsp.ncvc.go.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Angina Pectoris, Variant / etiology*
Drug-Eluting Stents / adverse effects*
Endothelium, Vascular / drug effects*,  physiopathology
Humans
Immunosuppressive Agents / administration & dosage,  adverse effects*
Male
Sirolimus / administration & dosage,  adverse effects*
Time Factors
Chemical
Reg. No./Substance:
0/Immunosuppressive Agents; 53123-88-9/Sirolimus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiac mass presenting as ST-elevation myocardial infarction: case report and review of the literat...
Next Document:  A variant of Takotsubo cardiomyopathy: a rare complication in the electrophysiology lab.